List of Tables
Table 1. Global Ulcerative Colitis Immunology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Ulcerative Colitis Immunology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Ulcerative Colitis Immunology Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Ulcerative Colitis Immunology Drugs Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Ulcerative Colitis Immunology Drugs Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Ulcerative Colitis Immunology Drugs Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Ulcerative Colitis Immunology Drugs Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Ulcerative Colitis Immunology Drugs, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Ulcerative Colitis Immunology Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ulcerative Colitis Immunology Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Ulcerative Colitis Immunology Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ulcerative Colitis Immunology Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ulcerative Colitis Immunology Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ulcerative Colitis Immunology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Ulcerative Colitis Immunology Drugs Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Region (2018-2023)
Table 19. Global Ulcerative Colitis Immunology Drugs Sales by Region (2024-2029) & (K Pcs)
Table 20. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Region (2024-2029)
Table 21. Global Ulcerative Colitis Immunology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Region (2018-2023)
Table 23. Global Ulcerative Colitis Immunology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Region (2024-2029)
Table 25. North America Ulcerative Colitis Immunology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Ulcerative Colitis Immunology Drugs Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Ulcerative Colitis Immunology Drugs Sales by Country (2024-2029) & (K Pcs)
Table 28. North America Ulcerative Colitis Immunology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Ulcerative Colitis Immunology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Ulcerative Colitis Immunology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Ulcerative Colitis Immunology Drugs Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Ulcerative Colitis Immunology Drugs Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe Ulcerative Colitis Immunology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Ulcerative Colitis Immunology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Ulcerative Colitis Immunology Drugs Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Ulcerative Colitis Immunology Drugs Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Ulcerative Colitis Immunology Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Ulcerative Colitis Immunology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Ulcerative Colitis Immunology Drugs Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Ulcerative Colitis Immunology Drugs Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America Ulcerative Colitis Immunology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Ulcerative Colitis Immunology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Ulcerative Colitis Immunology Drugs Sales (K Pcs) by Type (2018-2023)
Table 51. Global Ulcerative Colitis Immunology Drugs Sales (K Pcs) by Type (2024-2029)
Table 52. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2018-2023)
Table 53. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Type (2024-2029)
Table 54. Global Ulcerative Colitis Immunology Drugs Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Ulcerative Colitis Immunology Drugs Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Type (2018-2023)
Table 57. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Type (2024-2029)
Table 58. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Type (2024-2029)
Table 60. Global Ulcerative Colitis Immunology Drugs Sales (K Pcs) by Application (2018-2023)
Table 61. Global Ulcerative Colitis Immunology Drugs Sales (K Pcs) by Application (2024-2029)
Table 62. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2018-2023)
Table 63. Global Ulcerative Colitis Immunology Drugs Sales Market Share by Application (2024-2029)
Table 64. Global Ulcerative Colitis Immunology Drugs Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Ulcerative Colitis Immunology Drugs Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Application (2018-2023)
Table 67. Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Application (2024-2029)
Table 68. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Application (2024-2029)
Table 70. Janssen Biotech, Inc. Corporation Information
Table 71. Janssen Biotech, Inc. Description and Business Overview
Table 72. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product
Table 74. Janssen Biotech, Inc. Recent Developments/Updates
Table 75. Bristol-Myers Squibb Company Corporation Information
Table 76. Bristol-Myers Squibb Company Description and Business Overview
Table 77. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product
Table 79. Bristol-Myers Squibb Company Recent Developments/Updates
Table 80. AbbVie Inc. Corporation Information
Table 81. AbbVie Inc. Description and Business Overview
Table 82. AbbVie Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. AbbVie Inc. Ulcerative Colitis Immunology Drugs Product
Table 84. AbbVie Inc. Recent Developments/Updates
Table 85. UCBCares Corporation Information
Table 86. UCBCares Description and Business Overview
Table 87. UCBCares Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. UCBCares Ulcerative Colitis Immunology Drugs Product
Table 89. UCBCares Recent Developments/Updates
Table 90. AMGEN Corporation Information
Table 91. AMGEN Description and Business Overview
Table 92. AMGEN Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. AMGEN Ulcerative Colitis Immunology Drugs Product
Table 94. AMGEN Recent Developments/Updates
Table 95. Celltrion Healthcare Corporation Information
Table 96. Celltrion Healthcare Description and Business Overview
Table 97. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product
Table 99. Celltrion Healthcare Recent Developments/Updates
Table 100. Biogen Corporation Information
Table 101. Biogen Description and Business Overview
Table 102. Biogen Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Biogen Ulcerative Colitis Immunology Drugs Product
Table 104. Biogen Recent Developments/Updates
Table 105. Genentech USA, Inc. Corporation Information
Table 106. Genentech USA, Inc. Description and Business Overview
Table 107. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product
Table 109. Genentech USA, Inc. Recent Developments/Updates
Table 110. ROCHE Corporation Information
Table 111. ROCHE Description and Business Overview
Table 112. ROCHE Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. ROCHE Ulcerative Colitis Immunology Drugs Product
Table 114. ROCHE Recent Developments/Updates
Table 115. Pfizer Inc. Corporation Information
Table 116. Pfizer Inc. Description and Business Overview
Table 117. Pfizer Inc. Ulcerative Colitis Immunology Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Pfizer Inc. Ulcerative Colitis Immunology Drugs Product
Table 119. Pfizer Inc. Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Ulcerative Colitis Immunology Drugs Distributors List
Table 123. Ulcerative Colitis Immunology Drugs Customers List
Table 124. Ulcerative Colitis Immunology Drugs Market Trends
Table 125. Ulcerative Colitis Immunology Drugs Market Drivers
Table 126. Ulcerative Colitis Immunology Drugs Market Challenges
Table 127. Ulcerative Colitis Immunology Drugs Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ulcerative Colitis Immunology Drugs
Figure 2. Global Ulcerative Colitis Immunology Drugs Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Ulcerative Colitis Immunology Drugs Market Share by Type in 2022 & 2029
Figure 4. Adalimumab Product Picture
Figure 5. Certolizumab Pegol Product Picture
Figure 6. Tofacitinib Product Picture
Figure 7. Etanercept Product Picture
Figure 8. Golimumab Product Picture
Figure 9. Abatacept Product Picture
Figure 10. Infliximab Product Picture
Figure 11. Others Product Picture
Figure 12. Global Ulcerative Colitis Immunology Drugs Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 13. Global Ulcerative Colitis Immunology Drugs Market Share by Application in 2022 & 2029
Figure 14. Rheumatoid Arthritis
Figure 15. Crohn's Disease(CD)
Figure 16. Ankylosing Spondylitis(AS)
Figure 17. Psoriasis(Ps)
Figure 18. Ulcerative Colitis(UC)
Figure 19. Global Ulcerative Colitis Immunology Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Ulcerative Colitis Immunology Drugs Market Size (2018-2029) & (US$ Million)
Figure 21. Global Ulcerative Colitis Immunology Drugs Sales (2018-2029) & (K Pcs)
Figure 22. Global Ulcerative Colitis Immunology Drugs Average Price (USD/Pcs) & (2018-2029)
Figure 23. Ulcerative Colitis Immunology Drugs Report Years Considered
Figure 24. Ulcerative Colitis Immunology Drugs Sales Share by Manufacturers in 2022
Figure 25. Global Ulcerative Colitis Immunology Drugs Revenue Share by Manufacturers in 2022
Figure 26. The Global 5 and 10 Largest Ulcerative Colitis Immunology Drugs Players: Market Share by Revenue in 2022
Figure 27. Ulcerative Colitis Immunology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 28. Global Ulcerative Colitis Immunology Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 29. North America Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2018-2029)
Figure 30. North America Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2018-2029)
Figure 31. U.S. Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Canada Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Europe Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2018-2029)
Figure 34. Europe Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2018-2029)
Figure 35. Germany Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. France Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. U.K. Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Italy Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Russia Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Asia Pacific Ulcerative Colitis Immunology Drugs Sales Market Share by Region (2018-2029)
Figure 41. Asia Pacific Ulcerative Colitis Immunology Drugs Revenue Market Share by Region (2018-2029)
Figure 42. China Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Japan Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. South Korea Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. India Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Australia Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Taiwan Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Indonesia Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Thailand Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Malaysia Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Philippines Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Latin America Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2018-2029)
Figure 53. Latin America Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2018-2029)
Figure 54. Mexico Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Brazil Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Argentina Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Middle East & Africa Ulcerative Colitis Immunology Drugs Sales Market Share by Country (2018-2029)
Figure 58. Middle East & Africa Ulcerative Colitis Immunology Drugs Revenue Market Share by Country (2018-2029)
Figure 59. Turkey Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. Saudi Arabia Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. UAE Ulcerative Colitis Immunology Drugs Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 62. Global Sales Market Share of Ulcerative Colitis Immunology Drugs by Type (2018-2029)
Figure 63. Global Revenue Market Share of Ulcerative Colitis Immunology Drugs by Type (2018-2029)
Figure 64. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Type (2018-2029)
Figure 65. Global Sales Market Share of Ulcerative Colitis Immunology Drugs by Application (2018-2029)
Figure 66. Global Revenue Market Share of Ulcerative Colitis Immunology Drugs by Application (2018-2029)
Figure 67. Global Ulcerative Colitis Immunology Drugs Price (USD/Pcs) by Application (2018-2029)
Figure 68. Ulcerative Colitis Immunology Drugs Value Chain
Figure 69. Ulcerative Colitis Immunology Drugs Production Process
Figure 70. Channels of Distribution (Direct Vs Distribution)
Figure 71. Distributors Profiles
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed